Vaccinex, Inc.
VCNX- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001205922
No open-market purchases or sales by Vaccinex, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Vaccinex, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 25 | 27 | +2 |
| Shares | 4.25M | 4.64M | +393.6K (+9.3%) |
| Value | $5.49M | $5.03M | −$459.0K (−8.4%) |
New holders (5)
Institutions that held Vaccinex, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 44,648 | $48.0K | 0.00% |
| Goldman Sachs Group Inc | 22,472 | $24.0K | 0.00% |
| Virtu Financial LLC | 10,912 | $12.0K | 0.00% |
| Captrust Financial Advisors | 5,000 | $5.00K | 0.00% |
| Financial Connections Group, Inc. | 4,044 | $4.00K | 0.00% |
Sold out (3)
Institutions that held Vaccinex, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 226,593 | $299.0K |
| HRT Financial LP | 16,534 | $21.0K |
| Oppenheimer & Co Inc | 14,351 | $19.0K |